The ability to diagnose an imminent heart attack has long been considered the holy grail of cardiovascular medicine.

Of course, the medical profession doesn't like D.I.Y. anything.

About half of all people don't take medications like they're supposed to.

Not only can consumers handle their personal genetic information, but they are getting genomically oriented and anchored about such data.

The problem is that it takes physicians so long to accept a radical change. And the lag is unacceptable.

Medicine is still all about treating populations, not people - one-size-fits all treatments and diagnoses.

A lot of the diagnosis and monitoring functions will be done through little devices - smartphones - by the patient with computer assistance. So it's a real big change in the model of how we render healthcare.